OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production leverages Chinese hamster ovary (CHO) cells due to their efficiency in expressing complex molecules. Optimizing these processes involves modifying various parameters, including cell line development, media composition, and bioreactor settings. A key goal is to maximize antibody titer while reducing production costs a